Eli Lilly’s blockbuster antidepressant Cymbalta can now also be marketed as a treatment for chronic musculoskeletal pain, such as osteoarthritis and lower back pain, following FDA approval yesterday.
Continue r…
Unlike generics, which are the exact chemical copies of a brand-name drug, biosimilars have large and often complex proteins that are made in living cells, and tiny differences can play havoc with the product. It may take years…
The world’s biggest drugmaker reported earnings of $4.4 billion that topped estimates but revenues of $16.2 billion fell short of expectations.
Continue reading Pfizer Earnings Top Estimates, Boosts Guidance
…
At a liver disease conference in Boston, one highlight is expected to be reports from Achillion about its new hepatitis C treatments, especially ACH-1625. The buzz is growing that the little biotech is attracting the attention …
Russia’s police may have cut down the amount of spam in your inbox by opening an investigation of an alleged spam kingpin.
Russian officials began the investigation of Igor A. Gusev Tuesday, The New York Times reported. Officials said Gusev likely fled the country.
According to authorities, Gusev was a key player in the operations of SpamIt.Com, which paid spammers to promote online…
Continue reading Russia Investigates Alleged Spam Kingpin
Russia Investigates Alleged Spam Kingpin originally appeared on DailyFinance on Wed, 27 Oct 2010 06:47:00.
Filed Under: Technology, People, Media